Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1261931 | 0.79 | DRD2 (0.53) | DRD2PDPK1IDO1CYP11B2HTR2A | |
| SCHEMBL18408553 | 0.79 | DRD2 (0.53) | DRD2PDPK1IDO1CYP11B2HTR2A | |
| SCHEMBL9183567 | 0.79 | CYP11B2 (0.53) | PDPK1IDO1CYP11B2HTR2AMAOA | |
| SCHEMBL13198472 | 0.79 | OPRM1 (0.46) | DRD2 | |
| SCHEMBL14555196 | 0.78 | HTR2A (0.52) | DRD2PDPK1IDO1HTR2AHTR2C | |
| SCHEMBL14367929 | 0.76 | DRD2 (0.50) | DRD2PDPK1IDO1CYP11B2HTR2A | |
| SCHEMBL19419825 | 0.76 | DRD2 (0.50) | DRD2PDPK1IDO1CYP11B2HTR2A | |
| SCHEMBL21499446 | 0.76 | DRD2 (0.50) | DRD2PDPK1IDO1CYP11B2HTR2A | |
| SCHEMBL14169776 | 0.76 | DRD2 (0.50) | DRD2PDPK1IDO1CYP11B2HTR2A | |
| Methyl Alcohol SCHEMBL14815562 | 0.76 | DRD2 (0.50) | DRD2PDPK1IDO1CYP11B2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2185526-B1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIC-CARBOXAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2016-10-05 | — | — | EP | disclosed |
| US-8334390-B2 | Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-12-18 | — | — | US | disclosed |
| US-20100197925-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIC-CARBOXAMIDE DERIVATIVES | Bater SAS (FR) | 2010-08-05 | — | — | US | disclosed |
| WO-2009016218-A2 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIC-CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2009-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197925-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIC-CARBOXAMIDE DERIVATIVES | CBR3, CBR1, CYP3A7 | DRD2 1349/4885PDPK1 3782/4885IDO1 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.